EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER

The International Liver Congress 2020

 

25-28 August 2020 London
Close
N. Poster
Poster title
Applicant name
Status
  THU-010 PNPLA3 gene polymorphism and overall and cardiovascular mortality among non-alcoholic fatty liver disease in the United States Karn Wijarnpreecha Received Received
  SAT-012 Treatment with the endothelin receptor inhibitor bosentan alleviates the NAFLD-associated increased intrahepatic vascular resistance and reduces steatosis and liver damage in a rat model of early NAFLD Denise van der Graaff Received Received
  SAT-021 MicroRNAs involved in the progression of non-alcoholic fatty liver Guillermo Nahúm López-Sánchez Received Received
  THU-028 The association with low skeletal muscle mass and carotid atherosclerosis in patients with non-alcoholic fatty liver disease Min Kyu Kang Received Received
  THU-031 Histological renal damage and eligibility for kidney donation are worse in patients with biopsy-proven non-alcoholic steatohepatitis compared with simple steatosis Lorenzo Mulazzani Received Received
  SAT-059 TM6SF2 E167K variant increases the severity of NAFLD in high fat diet-fed mice Shousheng Liu Received Received
  FRI-071 Non-invasive liver fibrosis markers, FIB-4, PRO-C3 and ADAPT, are significantly elevated in biopsy confirmed NAFLD patients at high risk of developing coronary heart disease and cardiovascular disease and are promising clinical decision making tools Samuel Daniels Received Received
  THU-078 Inhibition of cytochrome P-4502E1 by clomethiazole improves alcoholic liver disease in alcohol-dependent patients: a short-term, randomized, controlled clinical trial Helmut Seitz Received Received
  FRI-097 Direct access lifestyle training improves liver biochemistry and causes weight loss but uptake is suboptimal in patients with NAFLD Imran Patanwala Received Received
  SAT-105 Characterization of alterations in mechanical, thermal and pain sensitivity in cirrhotic patients with minimal hepatic encephalopathy Carmina Montoliu Received Received
  SAT-130 Ammonia is an independent biomarker of poor outcomes in patients with advanced cirrhosis Gonalo Alexandrino Received Received
  SAT-133 Risk factors for sarcopenia and its impacts on clinical outcome in patients with liver cirrhosis Huijuan Xiao Received Received
  THU-139 Impaired splenic function in liver cirrhosis: a study in 69 patients with cirrhosis from outpatient hepatology clinic in a tertiary hospital in northern Greece Lamprini Kirkineska Received Received
  THU-143 Bile acids modify ROS production, impair chemotaxis and delay apoptosis of neutrophils in vitro Irina Komarova Received Received
  FRI-145 Antimitochondrial antibodies in patients with autoimmune hepatitis: a large multicenter study Nikolaos Gatselis Received Received
  THU-161 The therapeutic role of iNOS-expressed myeloid derived suppressor cells in acetaminophen induced acute liver failure Chien-Hao Huang Received Received
  THU-164 Ferroptosis related regulatory protein NCOA4 and its lncRNA-mRNA co-expression network in patients witn anti-tuberculosis drug-induced liver injury Jun Chen Received Received
  FRI-165 Understanding of central and peripheral fatigue in primary biliary cholangitis Naw April Phaw Received Received
  THU-176 Predictors of acute liver failure and death among patients with dengue-induced severe hepatitis Tongluk Teerasarntipan Received Received
  THU-180 The protective effects of a sense oligonucleotide drug targeting inducible nitric oxide synthase for a rat model of acute liver injury Richi Nakatake Received Received
  SAT-182 Protective effects of statin therapy in liver cirrhosis are limited by the common SLCO1B1 variant Melissa Merkel Received Received
  FRI-192 Artificial liver support system in hepatitis B virus-related acute-on-chronic liver failure patients Qian Zhang Received Received
  SAT-193 Tunnelated peritoneal catheter versus large volume paracentesis for refractory ascites in cirrhosis: a randomized controlled trial Nina Kimer Received Received
  SAT-201 Comparative study between spontaneous fungal peritonitis and spontaneous bacterial peritonitis in patients with end stage liver disease Mohamed Elnadry Received Received
  FRI-205 Granulocyte colony-stimulating factor in acute-on-chronic liver failure: systematic review and meta-analysis Rosa Martin- Mateos Received Received
  SAT-209 Spleen stiffness and liver stiffness for predicting high risk varices in patients with compensated liver cirrhosis Renata Fofiu Received Received
  THU-222 Reducing length of stay in patients following a liver transplant Abdulrhman Alamr Received Received
  SAT-225 Serum cholinesterase is an independent predictor of hepatic encephalopathy, acute-on-chronic liver failure and mortality after transjugular intrahepatic portosystemic shunt insertion in patients with liver cirrhosis Lena Thle Received Received
  SAT-226 Transjugular intrahepatic portosystemic shunt in cirrhotic elderly patients with refractory ascites - to do or not to do? Lena Thle Received Received
  SAT-231 Test-retest reliability of hepatic venous pressure gradient: a study in 215 patients from the control arms of 17 randomized controlled trials Wayne Bai Received Received
  SAT-236 Test-retest reliability of hepatic venous pressure gradient: a study in 215 patients from the control arms of 17 randomised controlled trials Wayne Bai Received Received
  SAT-237 Prognosis of alcoholic or viral B/C cirrhosis according to ABO blood group: results of abocirralvir, from CIRRAL and ANRS CO12 CirVir cohorts Isabelle Ollivier-Hourmand Received Received
  THU-251 Prophylactic rifaximin use in liver transplant candidates is associated with false positive results of the alcohol biomarker, ethyl sulphate Ian Webzell Received Received
  THU-262 Portal venous thrombosis and liver transplant: incidence and evolution in the 1st year after transplant MARIA ANGELES LOPEZ GARRIDO Received Received
  THU-263 Utility of anticoagulation in portal venous thrombosis before and after liver transplant MARIA ANGELES LOPEZ GARRIDO Received Received
  THU-266 The impact of gender and comorbidity burden on liver transplant eligibility and patient survival Marwan Ghabril Received Received
  SAT-270 Virtual touch quantification using acoustic radiation force impulse technology versus transient elastography for the non-invasive assessment of liver fibrosis in patients with chronic hepatitis B or C using liver biopsy as gold standard Baldea Victor Received Received
  FRI-277 Proteostasis improvement in cystic cholangiocytes alleviates endoplasmic reticulum stress and halts polycystic liver disease Alvaro Santos-Laso Received Received
  THU-281 Incidence and prognostic impact of cancer after liver transplantation Manuel Rodríguez-Perálvarez Received Received
  THU-288 An open-label, cohort study of grazoprevir/elbasvir combination therapy for patients with genotype 1b chronic hepatitis C after liver or kidney transplantation Teng-Yu Lee Received Received
  SAT-300 Unusual occurrence of hepatitis B infection in Upper Egypt Mahmoud S. Elzalabany Received Received
  FRI-322 Managing decompensated cirrhosis - the importance of multidisciplinary engagement Dev Katarey Received Received
  FRI-324 Prospective study of therapeutic education (TE) designed with a multidisciplinary team and participation of patients to improve the adherence to treatment of the patients and their quality of life (QOL) Dominique Larrey Received Received
  SAT-330 An OST (opiate substitution therapy)-based hepatology service facility (OHSF) with access to chronic hepatitis C treatment: the example of an one stop shop as a practical step towards HCV elimination in patients who use drugs (PWUD) Nikolaos Papadopoulos Received Received
  THU-333 Upregulation of CCNB1, CDC20 and CENPF genes is associated with poor prognosis in hepatocellular carcinoma (HCC) Tengfei Si Received Received
  THU-334 Bax inhibitor-1 inhibits acetaminophen induced hepatotoxicity by reducing the drug induced ER stress through regulating the RIDD activity of IRE1 alpha Thoufiqul Alam Riaz Received Received
  SAT-356 Hormone replacement therapy is associated with reduced liver cirrhosis risk and improved survival in treatment-naive hepatitis B- and/or C- infected postmenopausal women: a nationwide long-term population-based cohort study Yuan-Tsung Tseng Received Received
  THU-358 Risk of liver and non-liver-related mortality among hepatitis C virus and human immunodeficiency virus co-infected persons in a cohort of Brazilian blood donors: a twenty-year study Helio Ranes Filho Received Received
  SAT-359 Establishment of human induced pluripotent stem cell-derived hepatocyte-like cells permissive for serum-originated hepatitis B virus infection and allowing for covalently closed circular DNA inhibitor drug screening Chau-Ting Yeh Received Received
  THU-365 Global timing of hepatitis C virus elimination in high-income countries: an updated analysis Yuri Sanchez Gonzalez Received Received
  THU-366 Anticipated timing of elimination of hepatitis C virus in Canadas four most populous provinces Yuri Sanchez Gonzalez Received Received
  SAT-369 Validity of a point-of-care viral load kit for hepatitis B in a low-income setting Corina Rueegg Received Received
  SAT-376 Targeting hepatitis B virus with CRISPR/Cas9 approach Maria Guadalupe Martinez Received Received
  FRI-376 Is it possible to stop nucleus(t)die analogue safely in patients with preemptive or preventive therapy for HBV reactivation? Akihiro Tamori Received Received
  SAT-380 Prospective study of hepatitis B virus infection and its genotypes in the north-eastern India region Premashis Kar Received Received
  FRI-389 Risk of hepatitis flare in inflammatory bowel disease patients with previous hepatitis B virus exposure - results from a territory-wide Hong Kong ibd registry study Joyce Wing Yan Mak Received Received
  FRI-401 Impact if HBV infection in HCV/HBV coinfected patients treated with DAAs in north Italy Paolo Fabris Received Received
  THU-413 Health-related quality of life (HRQOL) before and after treatment of genotype 1 (GT1) infection with elbasvir/grazoprevir (EBR/GZR): results from the German hepatitis C registry (DHC-R) Markus Becker-Camps Received Received
  SAT-416 hzVSF, a novel HBV therapeutic candidate, shows WHsAg loss in woodchuck hepatitis model and safety in phase I clinical study Byoung Ahn Received Received
  SAT-422 ATI-2173, a novel phosphoramidate nucleoside prodrug for HBV cure regimens Douglas Mayers Received Received
  THU-423 Evolution of hepatitis C virus genotype 1a vs 1b distribution reflects profound changes in HCV epidemiology in Germany - analysis of 17,093 patients from five consecutive registries including the German hepatitis C-registry (DHC-R) Yvonne Serfert Received Received
  SAT-423 The role of HBV genotypes in HBV relapse after cessation of entecavir or tenofovir in HBeAg-negative patients without cirrhosis Chien-Hung Chen Received Received
  FRI-430 Development of hepatocellular carcinoma by patients aged 75 years or over after HCV elimination by all-oral DAA therapy: results from a large-scale, multicenter cohort study Eiichi Ogawa Received Received
  FRI-431 Deteriorated lipid profiles and cardio-cerebrovascular events after hepatitis C virus eradication Chung-Feng Huang Received Received
  THU-451 HCV DAA treatment failure is associated to hepatocellular carcinioma presence Ubaldo Visco-Comandini Received Received
  THU-461 Serum and urine extracellular vesicles contain specific RNAs with diagnostic capacity for cholangiocarcinoma, being possibly involved in disease pathogenesis Ainhoa Lapitz Received Received
  THU-462 Novel protein biomarkers in serum extracellular vesicles for the diagnosis of cholangiocarcinoma (CCA) in patients with primary sclerosing cholangitis (PSC) Ainhoa Lapitz Received Received
  THU-467 Serum cytokeratin-19 fragments (CYFRA 21-1) for the prediction of overall survival in patients with hepatocellular carcinoma Gian Paolo Caviglia Received Received
  SAT-484 HBsAg relapse after living donor liver transplantation in hepatocelluler carcinoma patients with hepatitis D virus infection may result in hepatocellular carcinoma relapse Adil Baskiran Received Received
  FRI-488 Modelling liver tumor organoids and cancer-associated fibroblasts interaction reveals the robust effects of stromal niche in cancer nurturing and treatment resistance Jiaye Liu Received Received
  SAT-504 Hepatic arterial infusion chemotherapy combined with sorafenib versus sorafenib monotherapy in advanced hepatocellular carcinoma: a systemic review and meta-analysis Zhiyuan Yao Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:30 Fri 8:30-15:00
11:25
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments
Captcha image
 

EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER

The International Liver Congress 2020

 

25-28 August 2020 London
HELP LINE
Manage Orders
FAQs


Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 25/08/2020 TO 25/08/2021
Poster
Gallery
Oral Presentation
& Video Gallery
Poster Discussion
Forum
                   DOI: 10.3252/pso.eu.ILC2020.2020 
PrintingOnline
Submit your poster online
in powerpoint format

   Poster submission deadline 03/08/2020
Upload Poster
Upload Oral Presentation of Video
Upload
Poster
Upload Oral
Presentation or Video




PosterSessionOnline
Logo Draft
 
Logo Cert